SMOX and Alzheimer disease: Polyamines dysregulation was confirmed in AD brains, and altered levels of PA metabolic enzyme transcripts (including an increase in SMOX mRNA) were suggested to promote tau neuropathology and induce cognitive and affective impairments [51].